These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19781972)

  • 1. [Crex and Orion analysis in radiation oncology: towards a mutualisation of corrective actions].
    Lartigau E; Vitoux A; Debouck F
    Cancer Radiother; 2009 Oct; 13(6-7):458-60. PubMed ID: 19781972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience feed back committee in radiotherapy (CREx): a compulsory tool for security management evaluation at two years].
    Lartigau E; Coche-Dequeant B; Dumortier V; Giscard S; Lacornerie T; Lasue A; Cheval V; Martel V; Malfait B; Fuchs A; Pestel M; Damman M; Forrest M
    Cancer Radiother; 2008 Nov; 12(6-7):610-3. PubMed ID: 18760652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From Crex mutualisation to clinical audit].
    Debouck F; Petit HB; Lartigau E
    Cancer Radiother; 2010 Oct; 14(6-7):571-5. PubMed ID: 20729118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Towards global security in radiation oncology. Using event notification feed-back].
    Woynar S; Debouck F; Cellier P; Bourhis J; Cauterman M; Lartigau E
    Cancer Radiother; 2007 Nov; 11(6-7):320-8. PubMed ID: 17959409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience feedback committees (CREX) and beyond…].
    Pourel N; Meyrieux-Croset C; Isambert A
    Cancer Radiother; 2015 Oct; 19(6-7):624-8. PubMed ID: 26344436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiotherapy safety: MEAH evaluation at three years].
    Talandier D; Tajahmady AT; Woynar S
    Cancer Radiother; 2009 Oct; 13(6-7):461-5. PubMed ID: 19695935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and quality assurance management in radiation oncology "what is the role for qualiticians?": example of the Centre Alexis Vautrin].
    Aigle D; Sobczyk C; Androni ML; Peiffert D; Beckendorf V; Marchesi V; Buchheit I; Noel A
    Cancer Radiother; 2009 Oct; 13(6-7):455-7. PubMed ID: 19695930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Report of adverse events related to treatments to Institute de Veille sanitaire].
    Maingon P; Simmon-Tellier S
    Cancer Radiother; 2007 Nov; 11(6-7):317-9. PubMed ID: 17870628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increasing quality and safety of external radiation treatments: actions of the French Society of Radiation Oncology (SFRO)].
    Mazeron JJ; Mornex F; Eschwege F; Lartigau E; Bolla M
    Cancer Radiother; 2008 Nov; 12(6-7):601-5. PubMed ID: 18835736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk analysis in radiation therapy: state of the art].
    Mazeron R; Aguini N; Deutsch É
    Cancer Radiother; 2013; 17(4):308-16, quiz 332. PubMed ID: 23787020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [French radiotherapy database: results of a survey of French radiation oncology centers in 2007].
    Chauvet B; Bolla M; Alies-Patin A; Bara C; Bourguignon M; Chantôme G; Eschwège F; Estivalet S; Fau P; Fournie E; Lipinski F; Mazeron JJ; Mornex F; Pointreau Y; Weissmann H
    Cancer Radiother; 2009 Oct; 13(6-7):466-70. PubMed ID: 19695925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing the evolution of radiotherapy quality assurance: in reference to Ford et al.
    Klein EE
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):664-6. PubMed ID: 19480967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epinal radiotherapy accident: passed, present, future].
    Peiffert D; Simon JM; Eschwege F
    Cancer Radiother; 2007 Nov; 11(6-7):309-12. PubMed ID: 17962063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation and quality assurance of equipment in radiation oncology].
    Bull Cancer Radiother; 1996; 83 Suppl 2():242s-272s. PubMed ID: 9084494
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care.
    Ishikura S
    Jpn J Clin Oncol; 2008 Nov; 38(11):723-9. PubMed ID: 18952706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost of quality assurance in radiotherapy: human and material requirements].
    Caudrelier V; Garcia R; Bourhis J; Chauvet B
    Cancer Radiother; 2005 Nov; 9(6-7):444-8. PubMed ID: 16257557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ORION®: a simple and effective method for systemic analysis of clinical events and precursors occurring in hospital practice].
    Debouck F; Rieger E; Petit H; Noël G; Ravinet L
    Cancer Radiother; 2012 May; 16(3):201-8. PubMed ID: 22424960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of the national standard for quality assurance of radiotherapy in oncologic patients].
    Kanaev SV; Vorogushin MF; Tikhomirov AS; Shishov VA
    Vopr Onkol; 2003; 49(5):668-75. PubMed ID: 14682145
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quality assurance in radiotherapy].
    Lisbona A; François P; Tomsej M
    Bull Cancer; 2010 Jul; 97(7):867-72. PubMed ID: 20570781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality in radiotherapy: effective treatment and patient safety.
    Nascimento A; Falzon P
    Work; 2012; 41 Suppl 1():1956-60. PubMed ID: 22317002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.